Latest Research in Bladder and Urothelial Cancer Treatments
120 research papers · 0.0 average citations · 2026 median publication year
Top Research Topics in Bladder and Urothelial Cancer Treatments
- Bladder and Urothelial Cancer Treatments — 17 papers
- Endometrial and Cervical Cancer Treatments — 11 papers
- Renal cell carcinoma treatment — 10 papers
- Inflammatory Biomarkers in Disease Prognosis — 9 papers
- Ovarian cancer diagnosis and treatment — 8 papers
- Global Cancer Incidence and Screening — 8 papers
- Gastric Cancer Management and Outcomes — 6 papers
- COVID-19 and healthcare impacts — 3 papers
- Esophageal Cancer Research and Treatment — 3 papers
- Head and Neck Cancer Studies — 3 papers
Highest-Cited Papers
- The Potential Role of Organ-to-Liver Ratios in Immune-Related FDG PET Imaging. Comment on Panikar et al. Exploratory FDG PET/CT Imaging in mCRPC Patients Treated with Sipuleucel-T ± IL-7: A Phase II Trial Subanalysis. Int. J. Mol. Sci. 2026, 27, 5129 (1 citations)
- Association of metformin exposure with oncological outcomes in BCG-treated non-muscle-invasive bladder cancer: a three-arm retrospective cohort study
- Role of cytoreductive nephrectomy in metastatic medullary renal cell carcinoma: controlled analysis
- Construction and Validation of a Nomogram Model for Predicting Cancer-Specific Survival in Colorectal Cancer Based on the SEER Database
- Diagnostic value of CEUS-VI-RADS for predicting muscle invasion in bladder cancer: Validation of the scoring system and introduction of tumor-bladder wall contact length as a supplementary quantitative metric
- Exploratory Analysis of the C-Reactive Protein–Albumin–Lymphocyte Index and Progression-Free Survival in Early-Stage Classical Hodgkin Lymphoma
- Risk of severe COVID-19 outcomes in individuals with prior cancer diagnosis – A nationwide Swedish register-based cohort study
- Occult pT2–4 disease and postoperative loss of full-dose cisplatin eligibility in CT-staged cT≤1/cN0 upper tract urothelial carcinoma
- Persistent Challenges in Nuclear Grading of Clear Cell Renal Cell Carcinoma: A Survey of Pathologists
- Incidence, sex ratio, and age distribution of oesophageal cancer in Tanzania: A population-based multi-registry analysis, 2019–2023
- Malignancies in horseshoe kidneys: an updated review
- Molecular Classifications and Candidate Biomarkers for Personalizing BCG Therapy in Non-Muscle-Invasive Bladder Cancer
- Adjuvant therapy for resectable gastrointestinal stromal tumors: evidence, controversies, and practical guidance
- Program-Level Neoadjuvant Chemotherapy Use and 10-Year Survival in Advanced Ovarian Cancer
- Fertility‐Sparing Treatment of Endometrial Cancer: Survey of Australian Practice
- The relationship between serum E2F1 and MMP-9 levels and clinical and pathological characteristics and prognosis in patients with epithelial ovarian cancer
- Smoking Status, Including Non-Combustible Nicotine or Tobacco Products Use, and Site-Specific Colorectal Cancer Risk: A Nationwide Cohort Study
- A multicenter phase II trial of ramucirumab plus irinotecan for early recurrence of gastric cancer during or after adjuvant chemotherapy with docetaxel plus S-1 therapy: the RAMIEL trial (OGSG1901)
- Sex Differences in Complications and Outcomes of Wilms Tumor: Is There a Role for Sex-based Approaches in Nephroblastoma Management?
- Prescribing Pattern with Treatment Approaches and Mortality Risk Assessment Using the Charlson Comorbidity Index in Head and Neck Cancer